← Explore exam analytics

Human Health and Disease · TOPIC LESSON

Cancer

Connect cell regulation, invasion, inheritance and evidence without turning a model into a diagnosis.

NEET UG32 min study guide13 indexed sections

BY THE END, YOU CAN

  • Distinguish regulated proliferation, benign growth, invasion and metastasis.
  • Compare proto-oncogene activation, tumour-suppressor loss and repair defects.
  • Separate inherited susceptibility from somatic change and cancer-associated infection.
  • Interpret original cell-count, geometry, screening and selection models with explicit assumptions.

BEFORE YOU START

  • Cell cycle and mitosis
  • Gene expression and mutation
  • Immune-system foundations

Original educational lesson. Work through the examples before revealing the practice answers. Check the current official syllabus separately; historical question frequency does not establish eligibility or predict future questions.

CONNECT THE CONCEPT TO THE EXAM

Selected exam questions & worked solutions

These selected examples are separate from the original practice below. Each identifies its exam, year and wording. They do not represent every paper or every selected year.

No source-verified exam questions have been published for this lesson yet. The worked examples and practice below are original teaching material, not past-exam questions.

01 / UNDERSTAND & APPLY

1. A failure of tissue regulation, not merely a fast mitosis

A tissue maintains itself through coordinated division, differentiation and cell loss. Cancer develops when an abnormal cell population escapes important controls and acquires malignant behaviour. The key question is not simply whether cells divide: bone marrow, developing tissues and a healing wound also require substantial normal proliferation.

Imagine two cell populations making the same number of new cells each day. If one removes damaged cells appropriately while the other retains them, their population sizes can diverge without any change in the duration of mitosis. Net accumulation depends on both production and loss.

The conventional textbook phrase uncontrolled growth is therefore shorthand for disrupted regulation, not a claim that every cancer cell is permanently in M phase or that all cancers grow at one rate. Some cells within a tumour may divide slowly or remain temporarily quiescent.

This lesson explains mechanisms and interpretation for biology study. Its examples are fictional models, not a screening guide or a way to classify a personal symptom. Clinical diagnosis, staging and treatment require qualified assessment and cancer-specific evidence.

02 / UNDERSTAND & APPLY

2. Behaviour and cellular origin answer different questions

A benign tumour is a nonmalignant growth that does not show the invasive and metastatic behaviour of a malignant tumour. Benign does not mean harmless in every location: a confined growth can compress a vital structure or disturb hormone secretion. Size alone cannot classify malignancy.

Invasion means extension into surrounding tissue. Metastasis means establishment of tumour growth at a separate site after dissemination. A malignant tumour need not already have a detectable distant metastasis when diagnosed; malignant potential and the currently observed extent are different issues.

Cancer is not synonymous with a visible solid lump. Leukaemias involve blood-forming lineages and generally do not present as a conventional solid tumour. Carcinomas arise from epithelial lineages, sarcomas from mesenchymal tissues such as bone or connective tissue, and lymphomas from lymphocytes.

Classification by origin should not be replaced by the destination of spread. If cells from a colon carcinoma establish a deposit in the liver, it remains metastatic colon cancer. The new location changes the distribution of disease, not the ancestral identity of that cell population.

03 / UNDERSTAND & APPLY

3. Normal controls operate at several levels

In a simplified culture model, many normal cells reduce proliferation when crowded by neighbours. Loss of this density-dependent inhibition can allow transformed cells to pile up rather than forming a restrained layer. This illustrates altered response to tissue context; it is not a single universal diagnostic test for every cancer.

Cell-cycle checkpoints coordinate readiness for DNA synthesis, completion of replication and chromosome attachment before segregation. A checkpoint is a control system, not a physical wall in the nucleus. Defective signalling can permit a damaged genome to be propagated.

Apoptosis is regulated cellular dismantling. Failure to eliminate seriously damaged cells can cooperate with proliferative signals. However, apoptosis is not the only control: differentiation, senescence, adhesion and communication with surrounding cells also influence tissue behaviour.

An exam statement that cancer means faster DNA replication in every cell is too narrow. A better explanation asks which restraint has failed, which survival advantage has appeared and whether the resulting population can invade its normal boundaries.

04 / UNDERSTAND & APPLY

4. Excess stimulation and missing restraint are different mechanisms

Proto-oncogenes are normal genes whose products participate in processes such as growth signalling and survival. Certain activating alterations or inappropriate increases in their expression can create oncogenic activity. The existence of a proto-oncogene in a healthy cell is normal, not evidence of hidden cancer.

Tumour-suppressor genes contribute restraints on proliferation or preserve other protective functions. Inactivation can remove part of that restraint. DNA-repair defects can instead raise the probability that additional changes accumulate. These categories are useful mechanistic groupings, although a protein can participate in more than one connected pathway.

The p53 pathway provides a familiar link between cellular stress, cell-cycle arrest and possible apoptosis. It is more accurate to describe p53 as a regulatory protein responding within a network than as an enzyme that personally repairs every damaged nucleotide.

In a deliberately simplified allele model, one constitutively active growth-signalling allele may influence the cell despite a normal partner. For many classic tumour suppressors, loss of both functional copies is important. These are teaching patterns, not universal rules covering every gene, dominant-negative effect or dosage-sensitive system.

Full-size scientific diagram. Swipe or scroll horizontally; keyboard users can focus the diagram and use arrow keys.

Positive signalling, protective restraint and DNA repairAn activating change in a proto-oncogene can create inappropriate positive signalling. Loss of tumour-suppressor function can remove protection. Defective DNA repair can add variation. These mechanisms can cooperate in abnormal population persistence.Different control failures can cooperateEXCESS POSITIVE SIGNALLOSS OF PROTECTIVE FUNCTIONProto-oncogeneNormal role in signalling / survivalCertain activating changesTumour-suppressor geneNormal protective contributionFunction lost or impairedOncogenic activityInappropriate growth / survival signalReduced restraintArrest or other protection can failAbnormal population can persistand accumulate further changesDNA-repair defects are another contributionMore unrepaired damage can create further variationNo single arrow guarantees cancer in every cell.Cell context, cooperating alterations and tissue interactions matter.
Original mechanism comparison, not a diagnostic classifier or a claim that every mutation has the same effect. Proto-oncogenes are normal cellular genes. The categories overlap in some biological pathways, and the diagram does not assert a universal number of required altered alleles.

05 / UNDERSTAND & APPLY

5. Genetic change and inherited predisposition must be separated

A somatic alteration arises in a body-cell lineage and can pass to that cell’s descendants through mitosis. It is not automatically present in gametes. A germline variant can be inherited by an offspring, potentially changing susceptibility across many tissues.

Inheritance of a susceptibility variant does not mean that a fully formed tumour is inherited. Further cellular events and other influences usually matter. Conversely, a person without a known inherited predisposition can still develop cancer through acquired changes.

The classic two-hit model helps distinguish levels of description. A child might inherit one impaired copy of a particular tumour-suppressor gene, leaving another copy functional in a cell. A later change affecting the remaining protection can contribute to tumour development in that lineage.

A predisposition can consequently appear dominant in a family pedigree even when loss of two functional copies matters at the cellular level. Dominance of increased risk in a pedigree and the molecular requirements within one cell are not interchangeable propositions.

06 / UNDERSTAND & APPLY

6. Carcinogens alter probabilities through biological mechanisms

A carcinogen is an agent capable of contributing to cancer development. Chemical constituents of tobacco smoke, ultraviolet radiation and ionising radiation are familiar categories. The mechanisms differ, so it is misleading to treat all radiation or all chemicals as biologically identical.

Ultraviolet radiation can damage DNA without being grouped with X-rays as ionising radiation. X-rays and gamma rays can produce ionisation and molecular damage. Exposure-associated damage is not equivalent to a guaranteed cancer outcome after every exposure; repair, dose, tissue context and other events influence risk.

An observed association is a starting point for causal reasoning. Useful evidence includes appropriate comparisons, temporality, consistency and a plausible mechanism. If two study groups differ in several relevant exposures, their outcome difference cannot be attributed confidently to one factor merely because that factor was measured.

Prevention reduces avoidable risk; it does not create a guarantee that every cancer can be prevented or that an affected person is to blame. Biology questions should analyse causes and uncertainty without turning a population association into a moral judgement about an individual.

07 / UNDERSTAND & APPLY

7. Some infections contribute to cancer through distinct routes

Certain high-risk human papillomaviruses can disrupt cell-regulatory pathways and contribute to cervical and other cancers. Persistent hepatitis B or hepatitis C infection can contribute to liver cancer. These examples do not imply that every viral infection is oncogenic or that every infected person develops cancer.

Helicobacter pylori is a bacterium associated with particular gastric cancers and gastric MALT lymphoma. Therefore, the category of cancer-associated infectious agents cannot be reduced to viruses alone. Chronic inflammation and altered tissue environments can be part of the causal connection.

HIV-associated immune impairment can increase susceptibility to some cancers and to infections involved in cancer development. This is a different explanation from claiming that HIV directly transforms every tumour cell. Distinguishing direct regulatory disruption, inflammation and impaired immune control improves matching questions.

An infectious agent may be transmissible while the cancer it contributes to is not spread by ordinary social contact. Vaccines against selected oncogenic infections can reduce some cancer risks, but there is no single vaccine preventing every cancer or reversing all established tumours.

08 / UNDERSTAND & APPLY

8. A distant tumour requires more than movement

In a simplified epithelial example, a basement membrane separates the epithelial compartment from underlying connective tissue. Local invasion involves breaching normal tissue boundaries. Entry into a blood or lymph vessel provides a possible route of dissemination, but transport alone does not establish a successful metastasis.

A disseminated cell must survive, leave the circulation in a suitable place and establish growth in another tissue. Many cells fail along this path. A diagram of the sequence describes necessary kinds of events without implying that every escaped cell inevitably forms a new tumour.

A growing tumour interacts with its microenvironment, including stromal cells, immune cells and vessels. Angiogenesis, the growth of new blood vessels, can support oxygen and nutrient delivery. It is a normal process in other contexts too, so its presence alone is not a definition of cancer.

Within a tumour, related subclones can differ. A treatment or changing environment may reduce sensitive populations while resistant populations survive and expand. Selection changes the proportions of existing variants; it does not mean cells deliberately design a mutation because they need it.

Full-size scientific diagram. Swipe or scroll horizontally; keyboard users can focus the diagram and use arrow keys.

Tissue boundaries and the metastatic cascadeA continuous basement membrane separates epithelial and connective-tissue compartments in the first panel. In the invasive panel, abnormal cells cross a break in that boundary and enter a distinct vessel lumen. The final panel separates transport, vessel exit and establishment of a distant population.Invasion and metastasis: distinct transitionsSimplified epithelial example; no fixed clinical timeline1. LOCAL COMPARTMENTContinuous basement membraneUnderlying connective tissue2. LOCAL INVASION AND VESSEL ENTRYBoundary breachedBlood-vessel lumen3. DISSEMINATION → DISTANT ESTABLISHMENTSurvival in transport → vessel exit → growth in another tissueMany disseminated cells fail; travel alone does not prove metastasis.
Original schematic of selected transitions in an epithelial cancer, not a universal progression or diagnostic image. The first panel establishes a boundary comparison without assigning a clinical stage. Vascular and tissue boundaries are shown schematically; successful metastasis requires additional survival and growth steps.

09 / UNDERSTAND & APPLY

9. Different tests reveal different kinds of evidence

Histopathology examines tissue architecture and cellular features from a sample, while cytology focuses on cells. A biopsy supplies material for examination; the act of taking a sample is distinct from the interpretation that follows. Molecular and immunological findings can complement morphology.

Imaging helps locate abnormalities and evaluate their distribution. CT uses X-rays, whereas MRI uses magnetic fields and radiofrequency signals. Neither method is a universal microscope that directly reveals every mutation or makes all tissue sampling unnecessary.

Antibodies can recognise selected cellular antigens in diagnostic work. A molecular marker can identify a relevant alteration, but one abnormal marker is not a universal yes/no test for all cancer. The target, sensitivity, specificity and clinical context determine what can be concluded.

Screening seeks evidence in people without the relevant symptoms, while diagnostic evaluation investigates a particular concern or abnormal finding. A positive screening result identifies a need for appropriate evaluation; it is not logically identical to a confirmed diagnosis.

10 / UNDERSTAND & APPLY

10. Mechanism explains both benefit and limitation

Surgery removes tissue at a selected site. Radiotherapy uses ionising radiation to damage cells in a treatment context. Chemotherapy includes drugs that interfere with important cellular processes, often affecting rapidly proliferating populations. These are broad categories, not interchangeable procedures.

Normal dividing cells may also be affected by cytotoxic treatment, helping explain why effects on blood-cell production, hair follicles or gastrointestinal lining can occur. This does not mean every medicine produces the same effects or that all cells respond equally.

Targeted therapy acts on particular molecular features, while immunotherapy modifies or recruits immune activity against cancer. The historical textbook example of alpha-interferon illustrates a biological-response modifier; it should not be presented as a universal current treatment for every cancer.

Combining modalities can address different biological problems, but the appropriate combination depends on tumour type, extent and patient factors. A conceptual lesson cannot choose a regimen. Apparent disappearance of a measurable mass and certainty that no malignant cell remains are also different claims.

11 / UNDERSTAND & APPLY

11. Count net population change before extrapolating

For a closed teaching population, next count equals starting count plus cells added through division minus cells lost. A single division of one mother into two daughters increases the population by one, not two, if the mother was already included in the starting count.

If every cell divides once per interval and none is lost, N = N₀ × 2ᵏ after k complete intervals. This idealisation is useful for arithmetic, not a clinical tumour-growth clock. Real populations vary in division probability, death, blood supply and available space.

Comparing diameter with cell number also needs a geometric assumption. For similarly shaped spheres with unchanged packing density, volume scales with the cube of diameter. Doubling diameter gives eight times the volume, whereas doubling volume multiplies diameter by the cube root of two.

Always identify whether a question gives diameter, volume, viable-cell count or a marker concentration. A change in one does not automatically specify an equal percentage change in every other measurement. Explicit assumptions are part of the answer, not optional decoration.

12 / UNDERSTAND & APPLY

12. Worked reasoning and quantitative models

These eight original cases test the stated assumptions. None represents a patient result or an official examination question.

ORIGINAL WORKED EXAMPLE

Two routes to accumulation

Population A starts with 1,000 cells, has 200 divisions and loses 200 cells. Population B starts with 1,000, has 200 divisions and loses 50. Each division replaces one mother with two daughters. Find final counts.

  1. Each division adds one net cell to the starting population.
  2. A: 1,000 + 200 − 200 = 1,000.
  3. B: 1,000 + 200 − 50 = 1,150; the difference is reduced loss.

Answer A stays at 1,000; B reaches 1,150 without a higher division count.

ORIGINAL WORKED EXAMPLE

Destination is not origin

A confirmed colon carcinoma gives rise to a liver deposit with matching lineage features. What is the deposit called?

  1. Identify the originating malignant lineage.
  2. The liver is the secondary location.
  3. Spread changes extent, not the ancestral classification.

Answer Metastatic colon cancer in the liver, not a new primary liver cancer merely because of its location.

ORIGINAL WORKED EXAMPLE

Pedigree and cellular levels

In a simplified model, inherited allele R* raises susceptibility, but a cell becomes strongly predisposed to transformation only after its remaining normal R copy is lost. Is dominant familial susceptibility inconsistent with two-copy cellular loss?

  1. The pedigree describes transmission of elevated risk.
  2. The cell model describes remaining molecular protection.
  3. Different levels of description can have different apparent dominance relationships.

Answer No. Dominant inheritance of susceptibility can coexist with a two-hit cellular model.

ORIGINAL WORKED EXAMPLE

An idealised doubling model

A closed model starts with 250 cells. Every cell divides once per interval, with no death or migration, for four intervals. Find the count.

  1. Four completed rounds multiply count by 2⁴ = 16.
  2. 250 × 16 = 4,000.
  3. The assumptions exclude the variability of real tumours.

Answer 4,000 cells; not a prediction of an actual tumour’s timeline.

ORIGINAL WORKED EXAMPLE

Diameter versus volume

Two model spherical masses have equal cell density. The second has twice the diameter of the first. What is its volume ratio?

  1. For similar spheres, volume is proportional to diameter cubed.
  2. Ratio = 2³ = 8.
  3. An eightfold volume ratio would imply an eightfold count only under the given equal-density assumption.

Answer 8:1 volume ratio, not 2:1.

ORIGINAL WORKED EXAMPLE

Reading a fictional screening table

In a teaching dataset, 80 people with the specified disease and 20 people without it have positive screening results. What fraction of positive results are true positives?

  1. The denominator is all positive results: 80 + 20 = 100.
  2. The numerator is true positives: 80.
  3. 80/100 = 0.80; this is positive predictive value for this dataset, not sensitivity.

Answer 80%; the figure cannot be transferred automatically to another population.

ORIGINAL WORKED EXAMPLE

Selection among subclones

A model contains 900 sensitive and 100 resistant cells. An intervention removes 90% of sensitive cells and none of the resistant cells. What is the resistant proportion immediately afterward?

  1. Sensitive survivors: 900 × 0.10 = 90.
  2. Resistant survivors: 100; total = 190.
  3. 100/190 ≈ 52.6%; resistance frequency rises even before reproduction.

Answer Approximately 52.6%, despite no increase in the absolute resistant-cell count.

ORIGINAL WORKED EXAMPLE

Compare two growth-control defects

Model X has a constitutively active growth signal. Model Y loses a protein that normally supports arrest after damage. Which resembles oncogenic activation and which resembles loss of tumour suppression?

  1. X adds inappropriate positive signalling.
  2. Y removes a protective restraint.
  3. The distinction is gain of inappropriate activity versus loss of protective function.

Answer X resembles oncogene activation; Y resembles tumour-suppressor loss.

13 / UNDERSTAND & APPLY

13. Original practice with explained answers

Check the mechanism and the level of inference before choosing a label.

ORIGINAL PRACTICE · 1

Does normal wound repair prove cancer because cells divide?

Reveal answer & reasoning

No.

Regulated proliferation is necessary in normal repair.

ORIGINAL PRACTICE · 2

Can a benign tumour cause serious harm?

Reveal answer & reasoning

Yes.

Location, pressure effects or secretion can matter even without malignant invasion.

ORIGINAL PRACTICE · 3

Must every malignant tumour already have a distant metastasis?

Reveal answer & reasoning

No.

Malignant behaviour and observed current spread are different questions.

ORIGINAL PRACTICE · 4

Which broad origin category includes epithelial cancers?

Reveal answer & reasoning

Carcinoma.

The classification refers to cell lineage, not just tumour location.

ORIGINAL PRACTICE · 5

Does every cancer form a solid lump?

Reveal answer & reasoning

No.

Leukaemias are an important counterexample.

ORIGINAL PRACTICE · 6

Are proto-oncogenes abnormal genes absent from healthy cells?

Reveal answer & reasoning

No.

They normally participate in growth and survival regulation.

ORIGINAL PRACTICE · 7

Does p53 directly repair every damaged base?

Reveal answer & reasoning

No.

It is part of a regulatory response that can influence arrest and apoptosis.

ORIGINAL PRACTICE · 8

Is a somatic tumour mutation automatically inherited by a child?

Reveal answer & reasoning

No.

Inheritance through offspring requires the relevant change in the germline.

ORIGINAL PRACTICE · 9

Is ultraviolet radiation classified here as ionising radiation like X-rays?

Reveal answer & reasoning

No.

UV can damage DNA without belonging to that ionising category.

ORIGINAL PRACTICE · 10

Name a bacterium linked to some gastric cancers.

Reveal answer & reasoning

Helicobacter pylori.

Cancer-associated infectious agents are not exclusively viruses.

ORIGINAL PRACTICE · 11

Does entry of a tumour cell into blood guarantee metastasis?

Reveal answer & reasoning

No.

Survival, exit and successful establishment remain necessary.

ORIGINAL PRACTICE · 12

Which uses X-rays: CT or MRI?

Reveal answer & reasoning

CT.

MRI uses magnetic fields and radiofrequency signals.

ORIGINAL PRACTICE · 13

Does one positive screening result always confirm cancer?

Reveal answer & reasoning

No.

False positives and context require appropriate further evaluation.

ORIGINAL PRACTICE · 14

A model has 400 cells, 80 divisions and 30 losses. What is the next count?

Reveal answer & reasoning

450 cells.

Each division adds one net cell: 400 + 80 − 30.

ORIGINAL PRACTICE · 15

A no-loss population of 125 cells completes three universal divisions. What is the count?

Reveal answer & reasoning

1,000 cells.

125 × 2³ = 1,000 under the stated assumptions.

ORIGINAL PRACTICE · 16

Why can resistant frequency rise without a new resistant mutation?

Reveal answer & reasoning

Sensitive cells can be removed preferentially.

Selection changes the denominator and relative abundance of existing variants.

KEEP THE BIG IDEAS

Quick revision

  • Net accumulation depends on both cell production and loss.
  • Malignancy is not classified by size alone, and distant deposits retain their originating lineage.
  • Genetic change is not synonymous with inherited disease.
  • Oncogenic stimulation, loss of restraint and impaired repair are distinct cooperating mechanisms.
  • A test result or growth model supports only the inference justified by its target and assumptions.
Back to the top ↑

READ WITH CONTEXT

References & scope

The teaching notes, worked explanations and original practice are written for this lesson. Separately labeled selected exam questions identify their exam, year, source and whether wording is paraphrased or an exact excerpt. Educational references do not certify current exam coverage.

Explore this topic in context

Analytics use a separately reviewed, incomplete historical corpus. Opening a topic does not change its counts or denominator.

KEEP EXPLORING

Your next idea is waiting.

Back to Biology index →Browse all topic notes